Cipla

IndusInd Bank, Yes Bank to join BSE Sensex; Cipla, Lupin exit

IndusInd Bank, Yes Bank to join BSE Sensex; Cipla, Lupin exit

The changes are announced by Asia Index, a joint venture between S&P Dow Jones Indices LLC and BSE. The move is a part of Asia Index's semi-annual reconstitution results.

Nov 17, 2017, 21:00 PM IST
Indian equities trade flat with marginal losses, healthcare stocks slip

Indian equities trade flat with marginal losses, healthcare stocks slip

On Thursday, weak services sector data and heavy selling pressure in banking and metal stocks dragged the benchmark indices lower.
 

Aug 04, 2017, 13:36 PM IST
Cancer drug: SC allows Cipla to withdraw appeal against Roche

Cancer drug: SC allows Cipla to withdraw appeal against Roche

The Supreme Court on Friday allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer drug, to withdraw its petition on the patent row.

Jun 16, 2017, 15:18 PM IST
Investor wealth surges over Rs 50 lakh crore in 3 years

Investor wealth surges over Rs 50 lakh crore in 3 years

Investor wealth has surged by over Rs 50 lakh crore since the Modi government was voted to power three years ago, with the Sensex surging to its lifetime high of 31,074.07 on Friday.

May 26, 2017, 18:08 PM IST

Cipla shares down 3%; mcap dips Rs 1,003 crore post Q4 results

Shares of pharma major Cipla on Friday fell by 3 percent after the company reported a consolidated net loss of Rs 61.79 crore for the March quarter.

May 26, 2017, 18:04 PM IST
Cipla gets USFDA nod for generic HIV drug

Cipla gets USFDA nod for generic HIV drug

Cipla has received approval from the US health regulator for its generic Abacavir and Lamivudine tablets used for treatment of HIV infection.

Apr 04, 2017, 15:14 PM IST
634 drugs on NPPA's price ceiling non-compliant list

634 drugs on NPPA's price ceiling non-compliant list

As many as 634 drugs of various strengths produced by firms, including Cipla, Abbott, Astrazeneca and Dr Reddy's, are "suspected" to be non-compliant with ceiling prices as notified by NPPA.

Feb 23, 2017, 23:33 PM IST
Cipla initiates campaign for a pollution free Delhi; starts #saveyourlungsdilli

Cipla initiates campaign for a pollution free Delhi; starts #saveyourlungsdilli

According to a TGI Survey, 34 percent (approx five million) of Delhi people are suffering respiratory problems including Asthma, Bronchitis, and Chronic Obstructive Pulmonary Disease. 

Jan 19, 2017, 20:33 PM IST

Cipla appoints Ireena Vittal as independent director

Drug major Cipla on Tuesday said it has appointed Ireena Vittal as an independent director on its board with effect from December 1, 2016.

Nov 29, 2016, 13:48 PM IST
Cipla gets four USFDA observations for three Goa facilities; stocks fall over 3%

Cipla gets four USFDA observations for three Goa facilities; stocks fall over 3%

Drug firm Cipla on Friday said the US health regulator has issued four observations across its three manufacturing facilities in Goa after the inspection.

Sep 30, 2016, 14:30 PM IST
Drug firms facing challenging times due to price control: Cipla

Drug firms facing challenging times due to price control: Cipla

 Drug companies are facing a tough environment due to the government bringing more products under the price control policy as also tightening of registration procedure that has impacted time to market newer products, Cipla Chairman YK Hamied has said.

Sep 29, 2016, 16:04 PM IST
Cipla, Godrej recognised in Fortune 'Change the World' list

Cipla, Godrej recognised in Fortune 'Change the World' list

India's pharmaceutical giant Cipla and consumer goods conglomerate Godrej have been recognised by Fortune magazine in a list of global firms changing the world for the good and having a positive social impact through their activities.

Aug 19, 2016, 14:50 PM IST

Cipla, Godrej Consumer Products in Fortune 'Change the World' list

Two Indian companies -- Cipla and Godrej Consumer Products -- have been named in Fortune magazine's list of top 50 companies that are addressing global social problems as part of their core business strategy.

Aug 18, 2016, 22:00 PM IST
Lupin Pharmaceuticals is India's most reputed pharma brand; Sun Pharma second

Lupin Pharmaceuticals is India's most reputed pharma brand; Sun Pharma second

Mumbai-based Lupin Pharmaceuticals is India`s most reputed pharmaceutical brand, said a report by Bluebytes, a leading media-analytics company on Wednesday.

Aug 17, 2016, 19:47 PM IST

FDCs banned over safety & efficacy concerns: Centre tells HC

The hearing in the matter would continue on April 4.  

Apr 01, 2016, 00:41 AM IST
Delhi High Court to resume hearing on petitions against Centre's ban on drugs

Delhi High Court to resume hearing on petitions against Centre's ban on drugs

Delhi High Court is likely to resume today the hearing on petitions by over 30 pharmaceutical majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government's decision to ban sale of some of their fixed dose combination medicines.

Mar 21, 2016, 07:32 AM IST

Cipla invests additional $ 3mn in US's Chase Pharmaceuticals

Drug firm Cipla Ltd has made an additional investment of USD 3 million in US-based Chase Pharmaceuticals engaged in developing novel approaches to improve treatments for Alzheimer's disease.

Mar 16, 2016, 13:33 PM IST

Antim Baazi: Action In Cairn India, Reliance & Cipla

Check out the action going in Cairn India, Reliance & Cipla.

Jan 19, 2016, 00:12 AM IST

Cipla sets up 6-member leadership team

Drug major Cipla on Thursday announced the creation of a 6-member 'Management Council' that will be the apex executive leadership team for the company.

Jan 07, 2016, 23:53 PM IST

Cipla launches generic hepatitis C drug in India

Drug major Cipla has launched generic tablets used for treating of hepatitis C under the brand name 'Hepcvir-L' costing Rs 25,000 for a bottle of 28 tablets in India.

Dec 21, 2015, 18:02 PM IST